CVS Health Corporation
CVS
$94.91
$0.900.96%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 7.14% | 6.15% | 8.40% | 7.76% | 8.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.14% | 6.15% | 8.40% | 7.76% | 8.35% |
| Cost of Revenue | 5.89% | 5.75% | 8.63% | 7.48% | 9.60% |
| Gross Profit | 15.28% | 8.46% | 6.83% | 9.71% | 0.90% |
| SG&A Expenses | 6.66% | 3.29% | 9.23% | 3.42% | 1.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.97% | 5.46% | 8.69% | 7.02% | 8.61% |
| Operating Income | 47.59% | 25.09% | -7.19% | 53.48% | 0.22% |
| Income Before Tax | 141.47% | 50.48% | -36.31% | -3,416.19% | -29.53% |
| Income Tax Expenses | 54.89% | 17.49% | -411.93% | 1,394.12% | 11.42% |
| Earnings from Continuing Operations | 195.66% | 65.94% | 80.10% | -5,719.72% | -42.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -300.00% | -366.67% | -4.76% | -6.25% | 300.00% |
| Net Income | 191.77% | 65.43% | 79.01% | -4,668.97% | -42.32% |
| EBIT | 47.59% | 25.09% | -7.19% | 53.48% | 0.22% |
| EBITDA | 32.26% | 17.70% | -4.37% | 29.21% | 0.67% |
| EPS Basic | 188.80% | 63.87% | 77.46% | -4,633.14% | -42.77% |
| Normalized Basic EPS | 55.31% | 27.55% | -19.67% | 61.80% | 2.56% |
| EPS Diluted | 188.75% | 63.12% | 76.56% | -4,633.14% | -43.23% |
| Normalized Diluted EPS | 54.83% | 27.26% | -19.98% | 61.80% | 2.48% |
| Average Basic Shares Outstanding | 1.03% | 0.95% | 0.87% | 0.79% | 0.80% |
| Average Diluted Shares Outstanding | 1.34% | 1.19% | 1.27% | 0.79% | 0.87% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | -0.65% | -0.39% | -0.44% | -1.02% | 0.75% |